Gregory Engel

Director/Board Member en Canadian Chamber of Commerce .

59 años

Health Technology

Consumer Services

Commercial Services

Perfil

Gregory Engel is currently a Director at the Canadian Chamber of Commerce and a Director at Clairvoyant Therapeutics, Inc. He was previously the Chief Executive Officer at Tilray Canada Ltd.
from 2015 to 2016, the Chief Executive Officer & Non-Independent Director at OrganiGram Holdings, Inc. from 2017 to 2021, and the General Manager at Forest Laboratories Canada, Inc. from 2010 to 2014.
He obtained an undergraduate degree from the University of Guelph.

Cargos activos de Gregory Engel

Empresas	Cargo	Inicio
Canadian Chamber of Commerce Canadian Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Canadian Chamber of Commerce is a chamber of commerce organization. The non-profit company is based in Ottawa, Canada.	Director/Board Member	30/10/2020
Clairvoyant Therapeutics, Inc. Clairvoyant Therapeutics, Inc. BiotechnologyHealth Technology Part of Origin Therapeutics Holdings, Inc., Clairvoyant Therapeutics, Inc. is a Canadian biotechnology company focused on mental health through psilocybin therapy. The private company is based in Vancouver, Canada. Clairvoyant is changing the face of psychedelic therapy with a speed-to-market clinical strategy designed to enable psilocybin therapy in the US, the EU, and to treat patients living with alcohol use disorder (AUD) beginning in 2026. Clairvoyant's exceptional team, with a proven clinical track record and deep drug development experience, has made it the most advanced company developing psilocybin therapy for the treatment of AUD. Clairvoyant was founded by Damian Kettlewell, Thomas Digby, and has been led by Damian Kettlewell as CEO since incorporation. Clairvoyant Therapeutics was acquired by Origin Therapeutics Holdings, Inc. on July 07, 2022.	Director/Board Member	-

Todos los cargos activos de Gregory Engel

Antiguos cargos conocidos de Gregory Engel.

Empresas	Cargo	Fin
ORGANIGRAM HOLDINGS INC.	Chief Executive Officer	03/05/2021
Tilray Canada Ltd. Tilray Canada Ltd. Pharmaceuticals: OtherHealth Technology Tilray Canada Ltd. provides ship medical cannabis to registered patients. The firm offers research and health policy, microbiology, plant genetics and drug development. The company is headquartered in Nanaimo, Canada.	Chief Executive Officer	01/06/2016
Forest Laboratories Canada, Inc. Forest Laboratories Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Forest Laboratories Canada, Inc. is a pharmaceutical company based in Saint John, Canada.	Corporate Officer/Principal	01/08/2014

Ver el detalle de la experiencia de Gregory Engel.

Formación de Gregory Engel.

University of Guelph

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Gregory Engel.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
ORGANIGRAM HOLDINGS INC.	Process Industries

Empresas privadas	4
Canadian Chamber of Commerce Canadian Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Canadian Chamber of Commerce is a chamber of commerce organization. The non-profit company is based in Ottawa, Canada.	Commercial Services
Forest Laboratories Canada, Inc. Forest Laboratories Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Forest Laboratories Canada, Inc. is a pharmaceutical company based in Saint John, Canada.	Health Technology
Tilray Canada Ltd. Tilray Canada Ltd. Pharmaceuticals: OtherHealth Technology Tilray Canada Ltd. provides ship medical cannabis to registered patients. The firm offers research and health policy, microbiology, plant genetics and drug development. The company is headquartered in Nanaimo, Canada.	Health Technology
Clairvoyant Therapeutics, Inc. Clairvoyant Therapeutics, Inc. BiotechnologyHealth Technology Part of Origin Therapeutics Holdings, Inc., Clairvoyant Therapeutics, Inc. is a Canadian biotechnology company focused on mental health through psilocybin therapy. The private company is based in Vancouver, Canada. Clairvoyant is changing the face of psychedelic therapy with a speed-to-market clinical strategy designed to enable psilocybin therapy in the US, the EU, and to treat patients living with alcohol use disorder (AUD) beginning in 2026. Clairvoyant's exceptional team, with a proven clinical track record and deep drug development experience, has made it the most advanced company developing psilocybin therapy for the treatment of AUD. Clairvoyant was founded by Damian Kettlewell, Thomas Digby, and has been led by Damian Kettlewell as CEO since incorporation. Clairvoyant Therapeutics was acquired by Origin Therapeutics Holdings, Inc. on July 07, 2022.	Health Technology

Ver las conexiones de la empresa